U.S. ARKRAY, Inc., a wholly owned subsidiary of ARKRAY, Inc., of Kyoto, Japan, has announced that the Food and Drug Administration has cleared its Fully Automated Integrated Urine Analyzer AUTION HYBRID AU-4050. This latest addition to the U.S. ARKRAY Inc., urinalysis portfolio combines the proven ARKRAY urinalysis strip technology with fluorescent flow cytometry sediment analysis in one space-efficient unit (32″x 28″). ARKRAY spokespersons stress that the attractive, compact size of the AUTION HYBRID AU-4050 does not compromise the level of performance that laboratories of all sizes demand. They also say that the AUTION HYBRID AU-4050 improves sample throughput capabilities, with continuous sample loading averaging a rate of 150 samples per hour. The full reflex testing capabilities allow laboratories to complete urine analysis on the same platform with minimal interaction.
“We are very excited to introduce the newest generation of the AUTION urinalysis instruments to the U.S. market,” says Susumu Akatsu, General Manager of U.S. ARKRAY Inc. “With the introduction of the AUTION HYBRID AU-4050, U.S. ARKRAY is now ready to offer full automation of urine chemistry and sediment analysis to all laboratories where the complete automation of urinalysis is critical. The compact instrument size provides an extra benefit to any laboratory where space comes at a premium.” Read more details and learn about commercial availability.
